Search Legislation

The Medical Devices Regulations 2002

Changes to legislation:

The Medical Devices Regulations 2002 is up to date with all changes known to be in force on or before 16 August 2022. There are changes that may be brought into force at a future date. Help about Changes to Legislation

Close

Changes to Legislation

Revised legislation carried on this site may not be fully up to date. Changes and effects are recorded by our editorial team in lists which can be found in the ‘Changes to Legislation’ area. Where those effects have yet to be applied to the text of the legislation by the editorial team they are also listed alongside the affected provisions when you open the content using the Table of Contents below.

  1. Introductory Text

  2. PART I Introductory Provisions Relating to all Medical Devices

    1. 1. Citation and commencement

    2. 1ZA.Expiry of certain provisions in these Regulations

    3. 1A.Schedules

    4. 2. Interpretation

    5. 2A. Medical devices which are qualifying Northern Ireland goods

    6. 3. Scope of these Regulations

    7. 3ZA.Revocation, transitional and saving provisions in respect of Regulation (EU) 2017/745

    8. 3A.Designated standard

    9. 3B.Confidentiality

    10. 4. Transitional provisions

    11. 4A.Transitional provisions for hip, knee and shoulder replacements

    12. 4D.Revocations, transitional and saving provisions in respect of the new national registration requirements

    13. 4H.Revocation of Commission Decision 2002/364 on 26th May 2025 and its effect before that date

    14. 4I.Revocation of Commission Decision 2010/227

    15. 4J.Revocation of Commission Regulation (EU) No 207/2012 on 26th May 2025

    16. 4K.Revocation of Regulation (EU) No 722/2012 on 26th May 2025

    17. 4L.Revocation of Regulation (EU) No 920/2013 on 26th May 2025 and its effect before that date

    18. 4M.Revocation of Regulation (EU) No 2017/2185 and saving provision

    19. 4N.The classification criteria in Directives 2003/12 and 2005/50

    20. 4O.Revocation of Regulation (EU) 2017/745

    21. 4P.Revocation of Regulation (EU) 2017/746

    22. 4T.References in other legislation to Directives 90/385, 93/42 and 98/79

  3. PART II General Medical Devices

    1. 5. Interpretation of Part II

    2. 6. Scope of Part II

    3. 7. Classification of general medical devices

    4. 7A.Registration of persons placing general medical devices on the market

    5. 8. Essential requirements for general medical devices

    6. 9. Determining compliance of general medical devices with relevant essential requirements

    7. 10. UK marking of general medical devices

    8. 10A.UK(NI) indication: general medical devices

    9. 11. UK marking of general medical devices that come within the scope of this Part and other legislation

    10. 12. Exemptions from regulations 8 and 10

    11. 13.Procedures for affixing a UK marking to general medical devices

    12. 14. Procedures for systems and procedure packs, and for devices to be sterilised before use

    13. 15. Procedures for custom-made general medical devices

    14. 16. Procedures for general medical devices for clinical investigations

    15. 17. Manufacturers etc. and conformity assessment procedures for general medical devices

    16. 18. Approved bodies and the conformity assessment procedures for general medical devices

    17. 19. Registration of persons placing general medical devices on the market

    18. 19A.Additional requirements relating to use of animal tissues

    19. 19B. Obligations in Part II of these Regulations which are met by complying with obligations in Directive 93/42

    20. 19C.Obligations in Part II and III of these Regulations which are met by complying with obligations in Regulation (EU) 2017/745

  4. PART III Active Implantable Medical Devices

    1. 20. Interpretation of Part III

    2. 21. Scope of Part III

    3. 21A.Registration of persons placing active implantable medical devices on the market

    4. 21B.Registration of persons placing active implantable medical devices on the market

    5. 21C.Requirement to appoint a UK responsible person for active implantable medical devices

    6. 22. Essential requirements for active implantable medical devices

    7. 23. Determining compliance of active implantable medical devices with relevant essential requirements

    8. 24. UK marking of active implantable medical devices

    9. 24A.UK(NI) indication: active implantable medical devices

    10. 25. UK marking of active implantable medical devices that come within the scope of this Part and other legislation

    11. 26. Exemptions from regulations 22 and 24

    12. 27. Procedures for affixing a UK marking to active implantable medical devices

    13. 28. Procedures for custom-made active implantable medical devices

    14. 29. Procedures for active implantable medical devices for clinical investigations

    15. 30. Manufacturers etc. and conformity assessment procedures for active implantable medical devices

    16. 30A. Obligations in Part III which are met by complying with obligations in Directive 90/385

    17. 31. Approved bodies and the conformity assessment procedures for active implantable medical devices

  5. PART IV In Vitro Diagnostic Medical Devices

    1. 32. Interpretation of Part IV

    2. 33. Scope of Part IV

    3. 33A.Registration etc. of persons placing in vitro diagnostic medical devices on the market

    4. 34. Essential requirements for in vitro diagnostic medical devices

    5. 34A.Approval requirement for coronavirus test devices

    6. 34B.Public sector use of coronavirus test devices

    7. 34C.Transitional provisions for coronavirus test devices

    8. 35. Determining compliance of in vitro diagnostic medical devices with relevant essential requirements

    9. 36. UK marking of in vitro diagnostic medical devices

    10. 36A.UK(NI) indication: in vitro diagnostic medical devices

    11. 37.UK marking of in vitro diagnostic devices that come within the scope of this Part and other legislation

    12. 38.In vitro diagnostic medical devices not ready for use

    13. 38A.Applications for approval of coronavirus test devices

    14. 38B.Performance requirements for coronavirus test devices

    15. 38C.Register of approved coronavirus test devices

    16. 39. Exemptions from this Part

    17. 39A.Exemptions for coronavirus test devices

    18. 40. Procedures for affixing a UK marking to in vitro diagnostic medical devices

    19. 41. Manufacturers etc. and conformity assessment procedures for in vitro diagnostic medical devices

    20. 42. Approved bodies and the conformity assessment procedures for in vitro diagnostic medical devices

    21. 43. Devices for performance evaluation

    22. 44. Registration of manufacturers etc. of in vitro diagnostic medical devices and devices for performance evaluation

    23. 44A. Requirement to appoint a UK responsible person for placing in vitro diagnostic medical devices on the market or for performance evaluation

    24. 44ZA. Obligations in Part IV which are met by complying with obligations in Directive 98/79

    25. 44ZB.Obligations in Part IV of these Regulations which are met by complying with obligations in Regulation (EU) 2017/746

  6. PART V Approved Bodies, Conformity Assessment Bodies and Marking of Products

    1. 44A.Interpretation of Part V

    2. A45.Meaning of approved body and UK notified body

    3. 45. Designation etc. of approved bodies

    4. 46.Choice of approved bodies and conformity assessment bodies

    5. 47.General matters relating to approved bodies

    6. 47A.Register of approved bodies

    7. 48. Designation etc. of ... conformity assessment bodies

    8. 49.Fees charged by approved bodies and conformity assessment bodies

    9. 50. Products incorrectly marked with an approved body or conformity assessment body number

    10. 51. Products incorrectly marked with a UK marking

  7. PART VI Fees charged by the Secretary of State

    1. 52. Interpretation of Part VI

    2. 53. Fees in connection with the registration of devices and changes to registration details

    3. 54. Fees payable in connection with the designation of approved bodies

    4. 55. Fees payable in connection with the designation etc. of ... conformity assessment bodies

    5. 56. Fees payable in relation to clinical investigation notices

    6. 56A.Fees in connection with approval of coronavirus test devices

    7. 57. Unpaid fees

    8. 58. Waivers, reductions and refunds

  8. PART VII General, Enforcement and Miscellaneous

    1. 59. Interpretation of Part VII

    2. 60.Status of UK responsible person

    3. 61. Enforcement etc.

    4. 62. Compliance notices

    5. 63. Restriction notices

    6. 64. Notification of decisions etc.

    7. 65. Centralised systems of records etc.

    8. 66. Revocations

    9. 67.Review

  9. Signature

    1. SCHEDULE 1

      ASSOCIATION AGREEMENTS

      1. 1.The Agreement establishing an Association between the European Economic Community...

    2. SCHEDULE 2

      MUTUAL RECOGNITION AGREEMENTS

      1. 1.The agreement on mutual recognition in relation to conformity assessment...

      2. 2.The agreement on mutual recognition in relation to conformity assessment...

      3. 3.The agreement on mutual recognition between the European Community and...

      4. 4.The agreement on mutual recognition between the European Community and...

      5. 5.The agreement between the European Community and the Swiss Confederation...

    3. SCHEDULE 2

      Mutual Recognition Agreement countries

      1. — Australia — New Zealand — Canada — The United...

    4. SCHEDULE 2A

      Modification of Annexes to Directives 90/385, 93/42, 98/79

      1. PART 1 Modification of Annexes to Directive 90/385

        1. 1.(1) The Annexes to Directive 90/385 are modified so that...

        2. 2.In Annex 1— (za) in Section 2, for “the functions...

        3. 3.In Annex 2— (a) for the heading substitute “Declaration of...

        4. 4.In Annex 3— (a) in the title for “EC TYPE-EXAMINATION”...

        5. 5.For Annex 4 substitute— ANNEX 4 VERIFICATION Verification is the procedure whereby the manufacturer ensures and declares...

        6. 6.For Annex 5, substitute— ANNEX 5 DECLARATION OF CONFORMITY TO...

        7. 7.In Annex 6— (a) in Section 1, for “authorised representative...

        8. 8.In Annex 7— (a) in Section 1.1 for “harmonised” substitute...

        9. 9.In Annex 8— (a) in the title for “when designating...

        10. 10.Omit Annex 9.

      2. PART 2 Modification of Annexes to Directive 93/42

        1. 11.(1) The Annexes to Directive 93/42 are modified so that...

        2. 12.In Annex I— (a) in Section 3, for “Article 1(2)(a)”...

        3. 13.In Annex II— (a) in the title omit “EC”;

        4. 14.In Annex III— (a) for each reference to “EC type-examination”...

        5. 15.In Annex IV— (a) omit “EC” (including in the title)...

        6. 16.In Annex V— (a) for “notified body” each time it...

        7. 17.In Annex VI— (a) omit “EC” each time it occurs...

        8. 18.In Annex VII— (a) in the title and in Section...

        9. 19.In Annex VIII— (a) in Section 1, for “authorized representative”...

        10. 20.In Annex IX for “this Directive” each time it occurs...

        11. 21.In Annex X— (a) in Section 1.1 for “harmonised standards”...

        12. 22.In Annex X1— (a) in the title, for “notified bodies”...

        13. 23.Omit Annex XII.

      3. PART 3 Modification of Annexes to Directive 98/79

        1. 24.(1) The Annexes to Directive 98/79 are modified so that...

        2. 25.In Annex 1— (a) in Section 3 in part A,...

        3. 26.In Annex III— (a) in the title and in Section...

        4. 27.In Annex IV— (a) in the title, omit “EC”;

        5. 28.In Annex V— (a) in the title, omit “EC” ;...

        6. 29.In Annex VI— (a) in the title omit “EC”;

        7. 30.In Annex VII— (a) in the title and in Section...

        8. 31.In Annex VIII— (a) in Section 1—

        9. 32.In Annex IX— (a) in the title, for “notified bodies”...

        10. 33.Omit Annex X.

  10. Explanatory Note

Back to top

Options/Help

Print Options

You have chosen to open The Whole Instrument

The Whole Instrument you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.

Would you like to continue?

You have chosen to open The Whole Instrument as a PDF

The Whole Instrument you have selected contains over 200 provisions and might take some time to download.

Would you like to continue?

You have chosen to open the Whole Instrument

The Whole Instrument you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.

Would you like to continue?

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as enacted version that was used for the print copy
  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

Timeline of Changes

This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.

Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as made version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources